FibroGen Share Drop After Failed Trial
FibroGen, a pharmaceutical company, experienced a major drop in its share prices after the announcement of its failed Phase 3 trial of pamrevlumab for treating idiopathic pulmonary...
FibroGen, a pharmaceutical company, experienced a major drop in its share prices after the announcement of its failed Phase 3 trial of pamrevlumab for treating idiopathic pulmonary...
More than 50 million people are expected to travel this upcoming Fourth of July weekend, breaking records and highlighting Americans' post-pandemic thirst for experiences, according to new...
European stocks experienced mixed performance on Monday. The Stoxx Europe 600 index (SXXP) decreased by 0.10% to 452.68, while the French CAC 40 index (PX1) rose 0.29%...
Daily Weighted Average Purchase Here is the daily weighted average purchase for transactions made on the market on different dates. Market Transaction Details Table shows the type...
Honda Motor Co. has announced that it is recalling approximately 1.2 million sport-utility vehicles and minivans. This recall is due to the rearview camera malfunction, which may...
WANdisco has revealed that interim CEO Stephen Kelly and interim CFO Ijoma Maluza will become permanent if the $30 million equity fundraise is successfully completed as the...
Let our financial advisors help you
© 2023, Myfinassets